Quantitative stock rating · as of 2026-11-05

Amneal Pharmaceuticals, Inc. (AMRX)

Name: Amneal Pharmaceuticals, Inc. (AMRX) Stock Rating: B+ (Strong)
Item: Amneal Pharmaceuticals, Inc.
Rating: B+
Author: QuantHarbor

B+

Strong

QuantHarbor five-lens rating band

Standout lens: Momentum.
Main drag: Valuation.

Price at the rating date (2026-11-05): $19.95.

The rating grades AMRX through five lenses — Quality, Valuation, Momentum, Growth Trend and Price Stability — computed from filings and market data, refreshed nightly. When data is too thin to score a lens, we withhold it instead of guessing.

See the full AMRX teardown free

Lens scores, the valuation zone, financial statement charts and the complete methodology are available with a free account. QuantHarbor is descriptive research, not investment advice.